Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trial.

Björklund E, Lindahl B, Stenestrand U, Swahn E, Dellborg M, Pehrsson K, Van De Werf F, Wallentin L; Swedish ASSENT-2.; RIKS-HIA Investigators..

Am Heart J. 2004 Oct;148(4):566-73.

PMID:
15459584
2.

International differences in in-hospital revascularization and outcomes following acute myocardial infarction: a multilevel analysis of patients in ASSENT-2.

Gupta M, Chang WC, Van de Werf F, Granger CB, Midodzi W, Barbash G, Pehrson K, Oto A, Toutouzas P, Jansky P, Armstrong PW; ASSENT II Investigators..

Eur Heart J. 2003 Sep;24(18):1640-50.

PMID:
14499226
3.
4.

Fibrinolytic therapy in patients 75 years and older with ST-segment-elevation myocardial infarction: one-year follow-up of a large prospective cohort.

Stenestrand U, Wallentin L; Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA)..

Arch Intern Med. 2003 Apr 28;163(8):965-71.

PMID:
12719207
5.

[Long-term follow-up of patients with acute myocardial infarction treated with primary angioplasty or thrombolysis. Results of the MITRA trial].

Zhan R, Schiele R, Schneider S, Gitt AK, Heer T, Wienbergen H, Seidl K, Glunz HG, Hauptmann KE, Voigtländer T, Gottwik M, Senges J; Maximale Individuelle Therapie beim Akuten Myokardinfarkt Studien Gruppe..

Z Kardiol. 2002 Jan;91(1):49-57. German.

PMID:
11963207
6.
7.

Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy.

Langer A, Krucoff MW, Klootwijk P, Simoons ML, Granger CB, Barr A, Califf RM, Armstrong PW.

J Am Coll Cardiol. 1998 Mar 15;31(4):783-9.

PMID:
9525547
8.

Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.

Weaver WD, White HD, Wilcox RG, Aylward PE, Morris D, Guerci A, Ohman EM, Barbash GI, Betriu A, Sadowski Z, Topol EJ, Califf RM.

JAMA. 1996 Mar 13;275(10):777-82.

PMID:
8598594
9.
10.

Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry.

Bahit MC, Cannon CP, Antman EM, Murphy SA, Gibson CM, McCabe CH, Braunwald E; TIMI 9 Trial and TIMI 9 Registry. Thrombolysis In Myocardial Infarction..

Am Heart J. 2003 Jan;145(1):109-17.

PMID:
12514662
11.

Thrombolysis and Q wave versus non-Q wave first acute myocardial infarction: a GUSTO-I substudy. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries Investigators.

Barbagelata A, Califf RM, Sgarbossa EB, Goodman SG, Stebbins AL, Granger CB, Suarez LD, Borruel M, Gates K, Starr S, Wagner GS.

J Am Coll Cardiol. 1997 Mar 15;29(4):770-7.

12.

Late assessment of thrombolytic efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. (LATE Study Investigators)

Langer A, Goodman SG, Topol EJ, Charlesworth A, Skene AM, Wilcox RG, Armstrong PW.

J Am Coll Cardiol. 1996 May;27(6):1327-32.

13.

Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial.

Steinberg BA, Moghbeli N, Buros J, Ruda M, Parkhomenko A, Raju BS, García-Castillo A, Janion M, Nicolau JC, Fox KA, Morrow DA, Gibson CM, Antman EM.

Am Heart J. 2007 Jul;154(1):54-61.

PMID:
17584551
14.

A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.

Cannon CP, McCabe CH, Henry TD, Schweiger MJ, Gibson RS, Mueller HS, Becker RC, Kleiman NS, Haugland JM, Anderson JL, et al.

J Am Coll Cardiol. 1994 Apr;23(5):993-1003.

PMID:
8144799
15.

Pre-hospital versus in-hospital thrombolysis for ST-elevation myocardial infarction.

McCaul M, Lourens A, Kredo T.

Cochrane Database Syst Rev. 2014 Sep 10;(9):CD010191. doi: 10.1002/14651858.CD010191.pub2. Review.

PMID:
25208209
17.
19.

High mortality with ST elevation myocardial infarction in a nontrial setting.

Shufelt KA, Paradiso-Hardy FL, Papastergiou J, Cohen EA.

Can J Cardiol. 2004 Dec;20(14):1455-9.

PMID:
15614341
20.

Patient outcomes after fibrinolytic therapy for acute myocardial infarction at hospitals with and without coronary revascularization capability.

Mehta RH, Criger DA, Granger CB, Pieper KK, Califf RM, Topol EJ, Bates ER.

J Am Coll Cardiol. 2002 Sep 18;40(6):1034-40; discussion 1041-3.

Supplemental Content

Support Center